Why The Medical Establishment Will Never Find A Cause Or Cure For Autism

February 24th, 2012

Natural News

By: Jonathan Benson

No matter how you look at it, autism research is big business. Just like the Susan G. Komen Foundation’s “Race for the Cure” for breast cancer, the autism industry pretends to be looking for the causes of autism and how to cure it, when in reality it is on a never-ending hunt for money to fund so-called research into the bodily changes associated with autism in order to push more profit-generating screenings and drug therapies on the public.

The worldwide propaganda campaign that continues to repeat the lie that vaccines are in no way related to autism is one great example of the medical establishment covering up one of the most obvious causes of autism. Rather than actually investigate how the body responds to vaccines, and how these responses are clearly associated with the neurological damage that is part and parcel of autism symptoms, researchers continue to churn out studies that completely avoid any investigation of this or any other likely cause of autism.

Instead, the vast majority of autism studies, which happen to be funded mostly by the pharmaceutical industry, focus solely on the physical, genetic, and chemical changes that accompany the disease, and ignore trying to identify the causes that lead to these changes in the first place. This approach is deliberate, of course, because it facilitates the development of an endless cycle of drug and behavioral therapies for autism that never get to the root of the problem, which means they will forever generate a continuous stream of new profits.

“To find a disease cause and solution to prevent disease isn’t profitable,” says a recent article in Gaia Health that addresses this important issue. “However, to find even the most miniscule physical, genetic, or chemical change in someone with an existing disease means that even more money can be squeezed out of the research funders like the National Institutes of Health (NIH) and the National Institute of Mental Health (NIMH), agencies funded by taxpayers. Anything that leads away from causes and focuses on the physiochemical effects of autism always leads to more questions and more research funds.”

The medical establishment seeks to destroy the lives, careers of researchers who actually try to identify causes of, and cures for disease. On the rare occasion that an honest researcher comes along and tries to actually conduct legitimate research into the causes of autism, he or she is eventually cut off from the funding chain, and sometimes even maligned and slandered in the public eye by the medical and media establishment. This is precisely what has happened to Dr. Andrew Wakefield, whose honest research into one cause of autism led to an ongoing barrage of character and career assassination that continues to this very day (http://www.naturalnews.com/Andrew_Wakefield.html).

Be sure to take a look at the sample studies on autism analyzed by Gaia Health that show a clear disinterest by the medical establishment in actually finding causes of, or cures for, autism. These studies are clearly aimed at discovering and promoting new drug and vaccine protocols for treating autism symptoms, rather than actually trying to prevent it from developing in the first place: http://gaia-health.com

For The Full Story Go To Natural News

Why The Medical Establishment Will Never Find A Cause Or Cure For Autism

February 24, 2012

Natural News

By Jonathan Benson

No matter how you look at it, autism research is big business. Just like the Susan G. Komen Foundation’s “Race for the Cure” for breast cancer, the autism industry pretends to be looking for the causes of autism and how to cure it, when in reality it is on a never-ending hunt for money to fund so-called research into the bodily changes associated with autism in order to push more profit-generating screenings and drug therapies on the public.

The worldwide propaganda campaign that continues to repeat the lie that vaccines are in no way related to autism is one great example of the medical establishment covering up one of the most obvious causes of autism. Rather than actually investigate how the body responds to vaccines, and how these responses are clearly associated with the neurological damage that is part and parcel of autism symptoms, researchers continue to churn out studies that completely avoid any investigation of this or any other likely cause of autism.

Instead, the vast majority of autism studies, which happen to be funded mostly by the pharmaceutical industry, focus solely on the physical, genetic, and chemical changes that accompany the disease, and ignore trying to identify the causes that lead to these changes in the first place. This approach is deliberate, of course, because it facilitates the development of an endless cycle of drug and behavioral therapies for autism that never get to the root of the problem, which means they will forever generate a continuous stream of new profits.

“To find a disease cause and solution to prevent disease isn’t profitable,” says a recent article in Gaia Health that addresses this important issue. “However, to find even the most miniscule physical, genetic, or chemical change in someone with an existing disease means that even more money can be squeezed out of the research funders like the National Institutes of Health (NIH) and the National Institute of Mental Health (NIMH), agencies funded by taxpayers. Anything that leads away from causes and focuses on the physiochemical effects of autism always leads to more questions and more research funds.”

Click here for the full report.

Alternative Meds Are Beating Out Conventional Meds

September 1, 2010

Natural News

by Jonathan Benson

Despite bearing the brunt of years of mockery from mainstream medicine, alternative remedies continue to gain in popularity among Americans who actually want to cure their ills and improve their health. According to researchers from the National Institutes of Health (NIH), about 40 percent of Americans today utilize some form of treatment that is not officially taught in Western medical schools.

In response to the growing popularity of alternative treatments back in the early 1990s, Congress passed legislation to fund a new division of health called the Office of Alternative Medicine (OAM). And in 1998, Congress officially established the National Center for Complementary and Alternative Medicine (NCCAM) to act as a liaison between the scientific community and the public in matters relating to alternative medicine.

Since that time, NCCAM has helped to provide scientific backing for many alternative treatments such as chiropractic and acupuncture that have become increasingly more popular amongst the mainstream public. Though not always in full support of every alternative and natural remedy out there, the center provides a wealth of useful information about many therapies, and it has helped increase the popularity of non-conventional treatments.

Alternative medicine includes a lot more than just massage therapy and back adjustments, though. Finding natural ways to cure allegedly incurable diseases is part of alternative medicine as well, and increasing numbers of people are turning to alternatives for the treatment of serious illnesses.

A recent VOANews.com article highlights the case of Ann Sterud, an ovarian cancer patient that had unsuccessfully tried for years to cure her cancer with conventional surgery and chemotherapy treatments. She eventually gave up on that and decided to try vitamin C infusions instead, even though this method of treatment is not officially recognized by Western medicine as viable.

“When you feel like your time is starting to run out, you feel you just have to go 100 percent and look for alternatives and that is what I did,” she said.

Click here to read the full report

Vitamin E Helps Treat Common Liver Disease

April 29, 2010

Google.com

by Alicia Chang

People with a common, obesity-related liver disease that has no known treatment got a surprising benefit from vitamin E pills, researchers reported Wednesday.

It appears to be the first time that a vitamin supplement has been shown to help treat a major ailment not caused by a nutrient deficiency. However, doctors warned that this does not mean people should automatically take vitamin E since some research suggests it might raise the risk of other problems.

The latest study tested it for nonalcoholic fatty liver disease. Fat buildup can cause the liver to become inflamed and scarred over time and in severe cases, to fail.

The disease usually develops in people who are middle-aged and overweight or obese. Up to 5 percent of Americans have the most serious form of it, and as many as 20 percent have fat in their livers but no organ damage.

In the study published online in the New England Journal of Medicine, 247 adults with advanced fatty liver disease were randomly assigned to take a high dose of vitamin E (800 international units), the diabetes drug Actos or dummy pills for nearly two years.

The vitamin and drug were tested because earlier research suggested liver cell deterioration and insulin resistance might be involved in the development of the disease.

Biopsies before and after treatment showed that liver function improved in 43 percent of those in the vitamin E group compared with 19 percent in the placebo group.

“In all honesty, I was surprised,” said the lead researcher, Dr. Arun Sanyal of Virginia Commonwealth University. “A vitamin has not been previously used to cure a serious disease” that is not caused by a deficiency.

Vitamin deficiency has been blamed for a range of health problems from rickets and osteoporosis from a lack of vitamin D to scurvy from not enough vitamin C.

Study participants on the diabetes drug Actos also improved, but to a lesser degree and with a drawback: gaining 10 pounds on average, which remained even after they stopped taking the drug. Four people who took vitamin E developed diabetes, but the study was too small to determine if the vitamin played any role.

The National Institutes of Health was the study’s main sponsor. A U.S. subsidiary of Japan-based Takeda Pharmaceutical provided the drug and California-based supplement maker Pharmavite supplied the vitamin E capsules. Sanyal, the lead researcher, has received consulting fees from Takeda and other drug companies.

Liver expert Dr. Sammy Saab at the University of California, Los Angeles, believes vitamin E could potentially become the initial treatment for advanced cases of the liver problem.

“For patients who are really at risk of progressive liver disease, I think it’s worthwhile. For the vast majority who just have fatty liver, I’m not sure it will help them at all,” said Saab, who had no role in the study.

Dr. Zobair Younossi, executive director of research at the nonprofit Inova Health System in Virginia, said people with nonalcoholic fatty liver disease at the very least should make lifestyle changes such as eating a healthy diet and exercising to shed the pounds.

While vitamin E may help certain people with obesity-related liver disease, “I wouldn’t get started on high-dose vitamin E without discussing it first with a doctor,” said Younossi, who has no connection to the research.

In recent years, hype over vitamin supplements in treating major diseases has not panned out. A 2008 study found that vitamins C and E pills do not ward off heart disease in men and vitamin E even appeared to raise the risk of bleeding strokes. Another study found the same supplements do not help prevent cancer in men.

Click here to read the full report

Panel Claims There is No Way To Prevent Alzheimers

April 29, 2010

Reuters.com

by Maggie Fox

Nor can any other supplements, drugs or social interaction, the independent panel meeting at the National Institutes of Health outside Washington concluded.

The group of experts looked at the dozens of studies that have suggested ways to prevent Alzheimer’s — a devastating and incurable breakdown of the brain — and found none were strong enough to constitute proof.

“We wish we could tell people that taking a pill or doing a puzzle every day would prevent this terrible disease, but current evidence doesn’t support this,” said Dr. Martha Daviglus of Northwestern University in Chicago, who chaired the panel.

Most of the studies that have been done show associations, but not cause and effect, Daviglus said.

“These associations are examples of the classic chicken or the egg quandary. Are people able to stay mentally sharp over time because they are physically active and socially engaged or are they simply more likely to stay physically active and socially engaged because they are mentally sharp?” she asked.

The 15 experts met under the NIH’s state-of-the-science conference program, which aims to direct future research in an important study area.

They included specialists in geriatrics, long-term care, nursing, psychiatry and other fields. Panelists may not be federal government employees, nor may they have financial stakes in any treatments considered.

DISEASE NOT FULLY UNDERSTOOD

The Alzheimer’s Association says as many as 5.3 million Americans have Alzheimer’s and projects that 16 million may have it by 2050.

“It is critical that we, as a nation, significantly increase investments in Alzheimer research,” the group said in a statement.

“The total payments for health and long-term care services for people with Alzheimer’s and other dementias will amount to $172 billion from all sources in 2010.”

The panel found there were inconsistent definitions of what constitutes Alzheimer’s disease and the cognitive decline that leads up to it.

Doctors also do not fully understand how the disease develops — for instance, there is disagreement on whether the amyloid plaques found in the brains of victims cause the disease or are merely a symptom.

There are a few drugs to treat Alzheimer’s but their effects are temporary. Genetics are strongly involved, and blacks and other minorities have a higher risk than whites.

Click here for the full report

Swine Flu Pandemic May Be Less Severe Than Expected

December 8, 2009

WebMD Health News

By Daniel J DeNoon

H1N1 swine flu won’t be as severe as was feared, but the pandemic is nothing to sneeze at, new predictions suggest.

When the fall/winter wave of H1N1 swine flu is over, it will have been no more severe than an average flu season, predict Harvard researcher Marc Lipsitch, DPhil, and colleagues from the U.K. Medical Research Council and the CDC.

“The good news is that … the severity of the H1N1 flu may be less than initially feared,” Lipsitch says in a news release.

There are some big asterisks next to that prediction:

    * Most of the deaths and hospitalizations in a typical flu season are elderly people. Most of those killed or hospitalized in the H1N1 swine flu pandemic are children and young adults.
    * Deaths attributed to seasonal flu include heart attacks, strokes, and other fatal conditions triggered by the flu. Nearly all deaths attributed to H1N1 flu are due to flu or to bacterial complications of flu.
    * The new predictions would be four or five times higher in populations without access to mechanical ventilation or intensive care.
    * All bets are off if the H1N1 swine flu shifts to older populations.

Even so, the new numbers are cause for relief if not for celebration. Before the 2009 H1N1 swine flu came along, planners were preparing for a pandemic with a case/fatality ratio of 0.1% — that is, for one death in every 1,000 symptomatic infections.

The Lipsitch team now calculates that the H1N1 swine flu has a case/fatality ratio no higher than 0.048% — and maybe seven to nine times lower, depending on the methods used for calculation.

“This is a serious disease,” Lipsitch says in the news release. He noted that between one in 70 and one in 600 people who fall ill with H1N1 swine flu will be hospitalized.

The CDC has been careful not to characterize the severity of the 2009 H1N1 pandemic. The new predictions are very much in line with CDC’s working estimates, says Beth Bell, MD, MPH, associate director for science at the CDC’s immunization and respiratory disease center.

“This study sends the message that this is primarily a young person’s disease and highlights the importance of taking advantage of this window of opportunity to get the vaccine and take preventive measures,” Bell tells WebMD. “While most people who get this illness do OK, it can be very severe — and the severity is concentrated in younger people.”
H1N1 Swine Flu: Same Lung Damage as 1918 Flu

Highlighting the H1N1 flu’s ability to turn deadly is a new study from James R. Gill, MD, from the New York City Medical Examiner’s office, and Jeffrey Taubenberger, MD, PhD, of the National Institutes of Health.

Detailed autopsies of 34 people who died of H1N1 swine flu show that the virus typically kills by damaging the upper airways, although damage in the lower airways and deep lung was not uncommon.

Strikingly, the damage was very familiar.

“This pattern of pathology in the airway tissues is similar to that reported in autopsy findings of victims of both the 1918 and 1957 influenza pandemics,” Taubenberger says in a news release.

Click here for the full report